Oxybenzone in people living in Canada

Learn about human biomonitoring of oxybenzone in Canada.

On this page

About oxybenzone

Oxybenzone, also known as benzophenone-3, is both a naturally occurring and a human-made chemical that absorbs ultraviolet (UV) radiation. Oxybenzone is widely used as a UV filtering chemical in self-care and consumer products.

Oxybenzone is used in self-care products to prevent harmful effects of the sun's UV radiation on the skin or hair. These products may include:

It is also used to prevent discoloration or deterioration from UV rays in consumer products such as:

People are exposed to oxybenzone by skin contact with sunscreens or self-care and consumer products that contain oxybenzone. Minor sources of exposure include eating foods (including human milk), drinking water, breathing air or swallowing dust contaminated with oxybenzone.

Oxybenzone is absorbed in the body after exposure. Oxybenzone is measured in a urine sample. The presence of oxybenzone in your urine reflects recent exposure to oxybenzone.

Potential health effects of oxybenzone

Studies in laboratory animals show that exposure to oxybenzone is associated with altered organ weights and adverse reproductive and developmental effects. Studies in human populations suggest possible:

It's important to note that the presence of a substance in your body doesn't necessarily mean it will affect your health.

What we're doing to lower human exposures to oxybenzone

We have:

We will:

Data sources for oxybenzone biomonitoring

This fact sheet presents human biomonitoring data from the Canadian Health Measures Survey (CHMS). You can access more results for oxybenzone and other UV absorbing compounds in the Canadian population through the Canadian biomonitoring dashboard.

Overview of biomonitoring initiatives for urinary oxybenzone in Canada
Initiative Collection period Target population
CHMS 2018 to 2019 General Canadian population aged 3 to 79 living in the 10 provinces

We wish to acknowledge all participants, including Indigenous peoples, who took part in the biomonitoring study.

Results of oxybenzone biomonitoring

Levels in the Canadian population

Oxybenzone was measured for the first time in the Canadian population from 2018 to 2019. The average level in urine was 16 µg/L.

Figure 1: Levels in the Canadian population, by age group

Average levels of oxybenzone were similar across age groups.

Levels in the Canadian population, by age group-see text description below
Text description
Table 1, Levels in Canadian population, by age group
Age group (years) Geometric mean level (µg/L) 95% confidence interval (µg/L)
3 to 5 26 10–66
6 to 11 25 14–47
12 to 19 19 12–31
20 to 39 15 10–24
40 to 59 16 9.7–25
60 to 79 15 9.1–24

Figure 2: Levels in the Canadian population, by sex

Average levels of oxybenzone were higher in females than in males.

Levels in the Canadian population, by sex-see text description below
Text description
Table 2, Levels in Canadian population, by sex
Sex Geometric mean level (µg/L) 95% confidence interval (µg/L)
Females 25 18–36
Males 11 6.8–17

Related links

How to cite this web page

Health Canada. 2024. Oxybenzone in people living in Canada. Ottawa, ON. Available: https://www.canada.ca/en/health-canada/services/environmental-workplace-health/reports-publications/environmental-contaminants/human-biomonitoring-resources/oxybenzone-in-people.html

Page details

Date modified: